News

Morphosys Reports Decreased Losses in Q2

1 Mins read

By Andrea Figueras

Morphosys, the German biopharmaceutical company, announced improved financial performance in the second quarter of the year. Despite a decline in revenue, lower costs helped narrow net and operating losses.

Strong Improvement in Financials

Morphosys reported a significant decrease in net loss for Q2, reducing it to 74 million euros ($81.2 million) compared to the previous year’s loss of EUR235 million. The company also saw a reduction in operating loss, with figures dropping from EUR55.1 million to EUR50.5 million.

Revenue Decline Offset by Cost Reductions

Although revenue dipped by 10% to EUR53.2 million, Morphosys successfully mitigated the impact through cost-cutting measures. The quarterly sales of Monjuvi, the company’s main product which treats lymphoma, remained stable at EUR21.7 million.

Positive Outlook for Monjuvi

Morphosys maintains a positive outlook for Monjuvi, anticipating net product sales in the U.S. to range between $80 million and $95 million for the year. The company expects a gross margin of 75% to 80% for Monjuvi and estimates research-and-development expenses to be between EUR290 million and EUR315 million.

Related posts
News

Tron Inc. Debuts on Nasdaq as Justin Sun Rings Opening Bell - TokenPost

1 Mins read
Tron Inc., the largest holder of TRX, has achieved a major milestone by officially listing on the Nasdaq exchange, marking a historic…
News

EFCC Takes Sensitization Campaign On Virtual Assets, Money Laundering To CBN - InfoStride News

2 Mins read
Operatives of the Benin Zonal Directorate of the Economic and Financial Crimes Commission, EFCC, on Thursday, July 24, sensitized officers of Central…
News

Binance's Top Trending Cryptocurrency Picks for Today, July 23, 2025

10 Mins read
Looking for what’s hot in crypto today, July 23, 2025? We’ve got the rundown on the top trending cryptocurrency picks you’ll find…

Leave a Reply

Your email address will not be published. Required fields are marked *

7 + 3 =